Faculty Opinions recommendation of Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717961403.793464209 ◽

2012 ◽

Author(s):

Charles Marc Samama

Keyword(s):

Randomized Trial ◽

Anticoagulation Therapy ◽

Thromboembolic Events ◽

Randomized Evaluation

Download Full-text

Faculty Opinions recommendation of Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717961403.793499805 ◽

2014 ◽

Author(s):

Jeffrey Weitz

Keyword(s):

Randomized Trial ◽

Anticoagulation Therapy ◽

Thromboembolic Events ◽

Randomized Evaluation

Download Full-text

Letter by David et al Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”

Circulation ◽

10.1161/circulationaha.112.133041 ◽

2013 ◽

Vol 127 (11) ◽

Author(s):

Jean Stephane David ◽

Vincent Piriou ◽

Pierre Albaladejo

Keyword(s):

Randomized Trial ◽

Anticoagulation Therapy ◽

Thromboembolic Events ◽

Randomized Evaluation

Download Full-text

Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”

Circulation ◽

10.1161/circulationaha.112.154732 ◽

2013 ◽

Vol 127 (11) ◽

Author(s):

Jeff S. Healey ◽

John Eikelboom ◽

Sean Yang ◽

Ellison Themeles ◽

Stuart J. Connolly ◽

...

Keyword(s):

Randomized Trial ◽

Anticoagulation Therapy ◽

Thromboembolic Events ◽

Randomized Evaluation

Download Full-text

Periprocedural Bleeding and Thromboembolic Events with Dabigatran Compared with Warfarin: Results from the Randomized Evaluation of Long-term Anticoagulation Therapy Randomized Trial

Journal of Emergency Medicine ◽

10.1016/j.jemermed.2012.09.008 ◽

2012 ◽

Vol 43 (5) ◽

pp. e381

Author(s):

Jordan Ryan

Keyword(s):

Randomized Trial ◽

Anticoagulation Therapy ◽

Thromboembolic Events ◽

Randomized Evaluation

Download Full-text

Letter by Hjemdahl et al Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”

Circulation ◽

10.1161/circulationaha.112.135343 ◽

2013 ◽

Vol 127 (11) ◽

Author(s):

Paul Hjemdahl ◽

Hans Johnsson ◽

N. Håkan Wallén

Keyword(s):

Randomized Trial ◽

Anticoagulation Therapy ◽

Thromboembolic Events ◽

Randomized Evaluation

Download Full-text

Faculty Opinions recommendation of Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717961998.793465540 ◽

2012 ◽

Author(s):

Jack Kron ◽

Eric Stecker

Keyword(s):

Dose Adjustment ◽

Anticoagulation Therapy ◽

Warfarin Dose ◽

Randomized Evaluation ◽

Anticoagulation Control

Download Full-text

Faculty Opinions recommendation of The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718122898.793533490 ◽

2017 ◽

Author(s):

J David Spence

Keyword(s):

Atrial Fibrillation ◽

Ischemic Stroke ◽

Major Bleeding ◽

Plasma Concentrations ◽

Anticoagulation Therapy ◽

Patient Characteristics ◽

Randomized Evaluation

Download Full-text

Letter by Bonaque et al Regarding Article, “Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy”

Circulation ◽

10.1161/circulationaha.112.114421 ◽

2013 ◽

Vol 127 (2) ◽

Author(s):

Juan C. Bonaque ◽

Germán Merchán ◽

Ichiro Ikuta

Keyword(s):

Atrial Fibrillation ◽

Anticoagulation Therapy ◽

Cardiac Biomarkers ◽

Randomized Evaluation ◽

Download Full-text

Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

American Heart Journal ◽

10.1016/j.ahj.2017.06.001 ◽

2017 ◽

Vol 190 ◽

pp. 94-103 ◽

Author(s):

Ziad Hijazi ◽

Jonas Oldgren ◽

Ulrika Andersson ◽

Stuart J. Connolly ◽

John W. Eikelboom ◽

...

Keyword(s):

Atrial Fibrillation ◽

Major Bleeding ◽

Anticoagulation Therapy ◽

Growth Differentiation Factor 15 ◽

Randomized Evaluation ◽

Differentiation Factor

Download Full-text

Response to Letter Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”

Circulation ◽

10.1161/circulationaha.114.012350 ◽

2014 ◽

Vol 130 (22) ◽

Author(s):

Ziad Hijazi ◽

Stefan H. Hohnloser ◽

Jonas Oldgren ◽

Ulrika Andersson ◽

Stuart J. Connolly ◽

...

Keyword(s):

Atrial Fibrillation ◽

Renal Function ◽

Anticoagulation Therapy ◽

Efficacy And Safety ◽

Randomized Evaluation ◽

Trial Analysis ◽

Therapy Trial ◽

Baseline Renal Function

Download Full-text